Our Advisors.

Dr. David Kerr, MBCHB, DM, FRCPE

Medical and Scientific Advisor

Dr. David Kerr is Director of Research and Innovation at the William Sansum Diabetes Center, Santa Barbara, CA and Director of mHealth Services for the Diabetes Technology Society. He was previously Consultant Physician at the Bournemouth Diabetes and Endocrine Centre in the UK.

Dr. Kerr’s research continues to focus on the use of technology for diabetes care, including the artificial pancreas and the new area of digital health. He is creator and co-founder of Diabetes Travel and ExCarbs, author of more than 200 peer-reviewed articles, Editor-in-Chief for Diabetes Digest (UK), and a regular blogger for the BMJ.

Dr. Kerr is also a Fellow of the Royal College of Physicians of Edinburgh, Visiting Professor at Bournemouth University and for many years has held a Gold Clinical Excellence Award from the National Health Service in the UK.

Dr. G. E. M. G. Storms, MD, PhD

Medical and Scientific Advisor

Dr. G. E. M. G. (Fred) Storms is one of the Netherlands’ leading authorities on the treatment of diabetes mellitus. Medical Director of the Diabetes Care team at St. Antonius Hospital, Utrecht until his retirement in 2016, Dr. Storms holds a special interest in the medical and technical advancements being made to improve diabetes treatment, and, as such, his work has long focussed on encouraging and supporting such advancements. He has participated in multiple international studies, including AT.LANTUS, PROactive, ONTARGET and EMPA-REG, and contributed to several trials of leading insulin pump therapies.

As well as serving as a medical advisor to the Dutch Diabetes Association (DVN), Dr. Storms was previously a senior advisor at the Dutch Institute for Healthcare Improvement (CBO), a public body committed to developing, implementing and reviewing professional and organisational quality within healthcare in the Netherlands. Through his role at CBO, Dr. Storms has taken part in four EU projects, collaborating with colleagues from across Europe. He continues this work on the EUBIROD Project, a working solution to fulfill the European Parliament’s 2012 resolution on addressing the diabetes epidemic in the EU through systematic data collections and the monitoring of diabetes complications and health outcomes across Europe.

He has also previously been an active member of the Dutch Internist Association (NIV) diabetes group, an invited member of the Dutch Ministry of Health’s diabetes task force and an extensive traveller, sharing his knowledge and expertise with professional and advocacy groups worldwide.